RNA Q2 2022 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-16.5% YoY

Gross Profit

-$38M-1726.9% margin

Operating Income

-$46M-2125.8% margin

Net Income

-$46M-2097.8% margin

EPS (Diluted)

$-0.92

QoQ Revenue Growth

+21.3%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$421M

Total Liabilities

$46M

Stockholders' Equity

$374M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-16.5%
Gross Profit	-$38M	-$20M	-87.1%
Operating Income	-$46M	-$26M	-75.6%
Net Income	-$46M	-$26M	-73.4%